StemCyte International, Ltd. (TPEX:4178)
27.10
+0.50 (1.88%)
At close: Mar 6, 2026
StemCyte International Revenue
StemCyte International had revenue of 197.31M TWD in the half year ending June 30, 2025, with 10.24% growth. This brings the company's revenue in the last twelve months to 385.12M, up 3.76% year-over-year. In the year 2024, StemCyte International had annual revenue of 382.69M with 5.49% growth.
Revenue (ttm)
385.12M
Revenue Growth
+3.76%
P/S Ratio
13.63
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.25B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| INTAI Technology | 2.41B |
| Progate Group | 1.35B |
| Aurona Industries | 1.30B |
| Pharmosa Biopharm | 136.72M |
| OBI Pharma | 49.29M |
| Asia Tech Image | 3.71B |
| VSO Electronics | 2.61B |
| Hye Technology Co.,Ltd | 480.58M |